Among these, we focused on miR-17-5p (hereafter simply referred to as miR-17), a miRNA that targets RUNX1-3′UTR, plays a key role in RUNX1-mediated control of myeloid differentiation [22], and is often upregulated in leukemia [24]. This evidence concerns the gene RUNX1 and leukemia.